Back to Search Start Over

Pharmacokinetics of tulathromycin in fetal sheep and pregnant ewes.

Authors :
MacKay EE
Washburn KE
Padgett AL
Fajt VR
Lo CP
Mays TP
Washburn SE
Source :
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2019 Jul; Vol. 42 (4), pp. 373-379. Date of Electronic Publication: 2019 Jan 17.
Publication Year :
2019

Abstract

Macrolides are important antimicrobials frequently used in human and veterinary medicine in the treatment of pregnant women and pregnant livestock. They may be useful for the control of infectious ovine abortion, which has economic, animal health, and human health impacts. In this study, catheters were surgically placed in the fetal vasculature and amnion of pregnant ewes at 115 (±2) days of gestation. Ewes were given a single dose of 2.5 mg/kg tulathromycin subcutaneously, and drug concentrations were determined in fetal plasma, maternal plasma, and amniotic fluid at 4, 8, 12, 24, 36, 48, 72, 144, and 288 hr after drug administration. Pharmacokinetic parameters in maternal plasma were estimated using noncompartmental analysis and were similar to those previously reported in nonpregnant ewes. Tulathromycin was present in fetal plasma and amniotic fluid, indicating therapeutic potential for use against organisms in these compartments, though concentrations were lower than those in maternal plasma. Time-course of drug concentrations in the fetus was quite different than that in the ewe, with plasma concentrations reaching a plateau at 4 hr and remaining at this concentration for the remainder of the sampling period (288 hr), raising questions about how tulathromycin may be transported into or metabolized and eliminated by the fetus.<br /> (© 2019 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2885
Volume :
42
Issue :
4
Database :
MEDLINE
Journal :
Journal of veterinary pharmacology and therapeutics
Publication Type :
Academic Journal
Accession number :
30656702
Full Text :
https://doi.org/10.1111/jvp.12744